Ion Labs Revenue and Competitors

Tampa, FL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Ion Labs's estimated annual revenue is currently $26.3M per year.(i)
  • Ion Labs's estimated revenue per employee is $201,000

Employee Data

  • Ion Labs has 131 Employees.(i)
  • Ion Labs grew their employee count by -6% last year.

Ion Labs's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
SVP Sales & Business DevelopmentReveal Email/Phone
3
VP Product DevelopmentReveal Email/Phone
4
Director Quality AssuranceReveal Email/Phone
5
Director SalesReveal Email/Phone
6
Facilities & Maintenance Director at ION LabsReveal Email/Phone
7
Director Business DevelopmentReveal Email/Phone
8
Director Quality ControlReveal Email/Phone
9
Director Human ResourcesReveal Email/Phone
10
Director Information TechnologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.5M132N/AN/AN/A
#2
$10.1M5014%N/AN/A
#3
$282.6M1406N/AN/AN/A
#4
$13.9M6944%N/AN/A
#5
$11.3M564%N/AN/A
#6
$11.5M57-7%N/AN/A
#7
$211.7M10724%N/AN/A
#8
$24.1M1205%N/AN/A
#9
$7.8M39-2%N/AN/A
#10
$12.9M64-2%N/AN/A
Add Company

What Is Ion Labs?

ABOUT US\n\nIon Labs, Inc. is a high quality, cGMP contract manufacturer that has been providing new and existing clients with the highest quality products in nutrition and health since 1983. We support our brand customers with product innovation & development through to full-service contract manufacturing. Ion Labs is an FDA-registered facility working to high standards in product quality. Specialisms include development & manufacture of dietary supplements, OTCs, Hemp/CBD products, pet supplements, and skin care products from our facility in Florida, United States of America.\nProduct formats include; tablets (including coated), hardshell capsules, liquid hardshell capsules, cap-in-cap, gummies, powders, OTC liquid, cosmetics skincare. And packaging: pots, jars, blisters, bottles, sachets, tubs and cartons. \nIon Labs Inc is now a DCC Health and Beauty Solutions businesses part of DCC Plc. The DCC Health and Beauty Solutions business in the USA includes Amerilab Technologies and Elite One source Nutritional Services, and in the UK, Laleham Health & Beauty Ltd, EuroCaps Ltd, Thompson & Capper Ltd and Design Plus Health & Beauty Ltd. \nwww.ionlabs.com\nwww.amerilabtech.com\nwww.eliteonesource.com\nwww.dcchealthandbeauty.com\nwww.laleham.com\nwww.thompsonandcapper.com\nwww.eurocaps.co.uk\nwww.designplusuk.com\n\nR&D\nWhether a product is required from concept, needs formulation enhancement, flavor improvement, or reverse engineering, we have the experience and supplier matrix to deliver. Ion Labs' R&D department works closely with our internal quality assurance and manufacturing divisions to support product development.\n\nANALYTICAL AUDITING, TESTING, & APPROVAL\nThe Quality Unit has final authority for approval or rejection of all phases of processing. It operates as a separate and distinct department of the company – this structure, in accordance with Good Manufacturing Practices, assures effective checks and balances to ensure& Beauty Solutions Companies and selected partners.

keywords:N/A

N/A

Total Funding

131

Number of Employees

$26.3M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ion Labs News

2022-04-20 - HED: Venture Capital, Expansion of the Ecosystem Among ...

“In Houston, we’ve launched The Ion, Halliburton Labs, Greentown Labs, a pretty broad range of incubators creating an ecosystem of...

2022-04-20 - Pityriasis Rubra Pilaris Treatment Market Set to Expand by ...

Pityriasis Rubra Pilaris Treatment Market Set to Expand by 2022-2029 Focusing on Key Players – GSK, Ion Labs, Roche, Pfizer, Sanofi.

2022-04-13 - A 4 V-Class Metal-Free Organic Lithium-Ion Battery Gets ...

Unlike conventional lithium-ion batteries, which depend on rare-earth ... Pipetting is a prevalent lab activity that constitutes a large...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M1328%N/A
#2
$36.7M1363%N/A
#3
$27.9M139-3%N/A
#4
$34.4M1425%N/A
#5
$33.6M1525%N/A